BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12703219)

  • 21. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.
    Elshami M; Ahmed FA; Hue JJ; Kakish H; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    Surgery; 2023 Feb; 173(2):289-298. PubMed ID: 36402613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left hepatic trisectionectomy for hepatobiliary malignancies.
    Lang H; Sotiropoulos GC; Brokalaki EI; Radtke A; Frilling A; Molmenti EP; Malagó M; Broelsch CE
    J Am Coll Surg; 2006 Sep; 203(3):311-21. PubMed ID: 16931303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary Tract and Primary Liver Tumors.
    Pawlik TM
    Surg Oncol Clin N Am; 2019 Oct; 28(4):xiii-xiv. PubMed ID: 31472919
    [No Abstract]   [Full Text] [Related]  

  • 24. Palliation of hepatic tumors.
    Cunningham SC; Choti MA; Bellavance EC; Pawlik TM
    Surg Oncol; 2007 Dec; 16(4):277-91. PubMed ID: 17935975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Top advances of the year: Hepatobiliary cancers.
    Coffman-D'Annibale KL; Greten TF
    Cancer; 2023 Apr; 129(8):1149-1155. PubMed ID: 36692965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems in staging of pancreatic and hepatobiliary tumours.
    Schmied BM; Z'graggen K; Redaelli CA; Büchler MW
    Ann Oncol; 2000; 11 Suppl 3():161-4. PubMed ID: 11079134
    [No Abstract]   [Full Text] [Related]  

  • 28. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 29. The new TNM classification in gastroenterology (1997).
    Endoscopy; 1998 Sep; 30(7):643-9. PubMed ID: 9826145
    [No Abstract]   [Full Text] [Related]  

  • 30. Obesity and hepatocellular carcinoma: hype and reality.
    El-Serag HB; Kanwal F
    Hepatology; 2014 Sep; 60(3):779-81. PubMed ID: 24753107
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of stage IVA hepatocellular carcinoma.
    Palavecino M; Wittekind C; Vauthey JN
    Arch Surg; 2008 Dec; 143(12):1235-6; author reply 1236. PubMed ID: 19075180
    [No Abstract]   [Full Text] [Related]  

  • 32. More options and improved outcomes for hepatocellular carcinoma.
    Scoggins CR
    J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver-directed treatment modalities for primary and secondary hepatic tumors.
    Yamane B; Weber S
    Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging for hepatocellular carcinoma: treatment strategy matters.
    Huo TI; Huang YH
    Hepatology; 2005 Mar; 41(3):678; author reply 678-9. PubMed ID: 15723331
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply: To PMID 24443059.
    Aleksandrova K; Pischon T
    Hepatology; 2015 Jul; 62(1):320-1. PubMed ID: 25475540
    [No Abstract]   [Full Text] [Related]  

  • 36. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.
    Lopez PM; Villanueva A; Roayaie S; Llovet JM
    Liver Transpl; 2006 Dec; 12(12):1747-54. PubMed ID: 17133591
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver, biliary tract, and pancreas.
    Monson JR; Fischer JE; Reber HA
    Curr Opin Gen Surg; 1994; ():147-50. PubMed ID: 7583951
    [No Abstract]   [Full Text] [Related]  

  • 38. [Key issues and prospects for the study on metastasis of hepatocellular carcinoma].
    Tang ZY
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1601. PubMed ID: 19094748
    [No Abstract]   [Full Text] [Related]  

  • 39. [Standard therapy for primary hepatocellular carcinoma].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):449-50. PubMed ID: 15329199
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
    Miller G; Schwartz LH; D'Angelica M
    Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.